Searched for
SUN PHARMA SHARES TUMBLE
Stocks in news: Emcure Pharma, Dixon Technologies, Ajanta Pharma, Godrej Properties, VedantaIndian markets experienced a volatile session, closing higher amidst mixed signals. Bulls are defending the 23,000 level in Nifty, but unce...- Promoter sells Rs 1,024 crore worth of Ajanta Pharma shares in block deal to Kotak MF and ABSL MFA promoter entity of Ajanta Pharma sold shares worth over Rs 1,024 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya B...
- SBI in $1 billion funding for Sun Pharma’s US dealState Bank of India is set to commit up to $1 billion to fund Sun Pharmaceutical Industries Ltd.'s $12 billion acquisition of Organon & Co....
- Last date to buy these 3 Tata Group stocks for dividends worth Rs 89. Do you own any?Investors have a final chance today to purchase shares in Tata Chemicals, Tata Elxsi, and Tata Investment Corporation. These three Tata Gro...
- Why market crashed today? Sensex plunges 719 points, Nifty closes below 23,150; 7 factors behind Rs 7 lakh crore sell-offIndian equity markets experienced a significant sell-off on Monday, with the Sensex and Nifty declining around 1% each. This downturn was d...
- We don't even know where LIC's office is: Rajesh Exports chief amid regulatory heatRajesh Exports Chairman Rajesh Mehta clarified LIC's investment in his company, stating the insurer bought shares over two decades from the...
- Sterlite Tech shares slide 5% after rallying 56% in one month. Here's whySterlite Technologies shares hit the lower circuit on Monday as a sharp global selloff in AI and technology stocks dented investor sentimen...
- US stock market crash explained: Why did Nasdaq plunge 4% to log worst day in over a yearWall Street experienced a sharp decline on Friday, led by the Nasdaq's significant fall, as a robust US jobs report fueled concerns about s...
- Hindustan Zinc shares tumble 5% to 6-week low after report of govt's plan to sell 2% stake for Rs 5,000 croreHindustan Zinc shares fell sharply on Friday after a report said the government may sell up to a 2% stake in the company to raise around Rs...
- Global Markets: Japan's Nikkei pulls back from record high on AI selloffJapan's Nikkei index experienced its biggest drop in three weeks on Thursday. This pullback followed a record high. Investors sold AI-relat...
- Broader markets crash! Physicswallah, Coforge, other small & midcap stocks tumble up to 6%. Do you own?Indian smallcap and midcap stocks plummeted on Wednesday due to persistent FII selling, a weakening rupee, and global factors. IT stocks, w...
- Market wrap: Sensex rises 383 points, Nifty closes near 23,500 as IT stocks shineIndian stock market staged a sharp recovery, with Sensex and Nifty erasing morning losses to snap a four-session losing streak, led by a st...
- Alkem rolls out single-shot semaglutide syringes at Rs 350 for diabetes, weight lossAlkem Laboratories has launched semaglutide in single-shot pre-filled syringes in India. This makes treatment more accessible and affordabl...
- NHPC shares tumble 5% as govt’s OFS worth up to Rs 4,300 crore opens at 8% discount. Check detailsNHPC Share Price: NHPC shares saw a significant drop of nearly 5 percent. This decline followed the government's launch of an offer for sal...
- Delhi HC allows Intas to sell cancer drug Bevatas, sets aside order favouring Sun PharmaThe Delhi High Court division bench has ruled in favor of Intas Pharmaceuticals, allowing the company to introduce its anti-cancer medicati...
- More macro headwinds on the cards? Tackle them with core principles: 6 pharma stocks with upside potential of up to 28%There was a time when the Indian pharma story in the US was almost entirely about inspection risk. The US FDA would inspect a plant, a warn...
- Why stock market crashed today? Sensex sinks 1,100 points, Nifty below 23,550. 4 key factorsIndian stock markets experienced a sharp downturn Friday, with Sensex and Nifty falling significantly due to persistent foreign investor se...
- Natco Pharma shares crash 15% after weak Q4 results; net profit tanks 34% YoYNatco Pharma shares plunged after the company reported a steep fall in fourth-quarter profit, revenue and EBITDA. Weak operating margins an...
- Sun Pharma sees steady FY27 growth, progresses $11.75 bn Organon integration dealSun Pharma anticipates strong growth in the coming years. The company expects a high single-digit increase in its overall sales by FY2027. ...
- Sun Pharma Q4 Results: Cons profit rises 26% YoY to Rs 2,714 crore; board approves Rs 5/share dividendSun Pharma Q4 Results: Profit after tax (PAT) fell 19% sequentially during the quarter under review from Rs 3,369 crore in Q3FY26, while re...
Load More
